Oncolytics Biotech Inc. (ONC.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 101.72M |
| Enterprise Value | 86.84M |
| P/E Ratio | -2.65 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -17.7 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.3 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -4.98 |
| Return On Equity | 10.2 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -424,000 |
| EBITDA | -34.88M |
| Net Income | -31.71M |
| Diluted EPS | -0.41 |
Balance Sheet
| Total Cash | 14.63M |
| Total Cash/Share | 0.03 |
| Total Debt | 888,000 |
| Total Debt/Equity | -0.07 |
| Current Ratio | 1.35 |
| Book Value Per Share | -0.05 |
Price History
| 52-Week Change | 15.45 |
| 52-Week High | 2.08 |
| 52-Week Low | 0.45 |
| Moving Average 50 Days | 1.31 |
| Moving Average 200 Days | 1.08 |
Statistics
| Average Volume | 285,775 |
| Shares Outstanding | 100.18M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 21:200 |
| Last Split Date | May 25, 2018 |
AD
